NEUTRAL GLYCOLIPID ANTIGENS
中性糖脂抗原
基本信息
- 批准号:2259426
- 负责人:
- 金额:$ 9.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-01 至 1996-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Guillain-Barre' syndrome (GBS) is an immune-mediated, inflammatory,
demyelinating polyneuropathy. In serum of GBS patients, complement
fixing antibodies against peripheral nerve myelin can be found, which
correlate with the clinical course and precede the appearance of
activated complement components in CSF, serum and peripheral nerve. A
significant portion of this Ab activity in some GBS patients is directed
against a neutral glycolipid of peripheral nerve myelin that
cross-reacts with Forssman antigen. Forssman is a component of several
viruses and bacteria, and heterophile responses accompanying many
infections are partly directed against Forssman antigen. In this
proposal we want to study the role of antibody and complement in
peripheral nerve demyelination in experimental allergic neuritis (EAN),
an animal model of GBS. Our specific aims are: 1) To study the
development of experimental allergic neuritis in the Lewis rat,
following immunization with Forssman antigen. 2) To determine which
epitope on Forssman is recognized by serum Ab from Forssman induced EAN
animals. 3) To determine if affinity-purified Ab from EAN serum can
cause demyelination following intraneural injection in Lewis rat sciatic
nerve. 4) To study the effect of complement depletion on blood-nerve
barrier integrity in EAN induced by peripheral nerve myelin.
Electrophysiologic testing and histologic studies will be done to assess
peripheral nerve demyelination in EAN, and after intraneural injection.
Immunological techniques to be used include ELISA, C1 fixation-transfer
assay and HPTLC.
格林-巴利综合征(GBS)是一种免疫介导的炎症性疾病,
脱髓鞘性多发性神经病 在GBS患者血清中,
可以发现抗周围神经髓鞘的固定抗体,
与临床病程相关,并先于
激活CSF、血清和外周神经中的补体成分。 一
在一些GBS患者中,该Ab活性的显著部分是针对
针对外周神经髓鞘的中性糖脂,
与福斯曼抗原有交叉反应 福斯曼是几个
病毒和细菌,以及伴随许多
感染部分针对福斯曼抗原。 在这
我们想研究抗体和补体在
实验性变态反应性神经炎(EAN)中的外周神经脱髓鞘,
GBS的动物模型。 我们的具体目标是:1)研究
在刘易斯大鼠中发生实验性过敏性神经炎,
用Forssman抗原免疫后。2)以确定哪些
Forssman上的表位被来自Forssman诱导的EAN的血清Ab识别
动物3)为了确定从EAN血清中亲和纯化的Ab是否可以
引起刘易斯大鼠坐骨神经内注射后脱髓鞘
神经。4)研究补体耗竭对血神经的影响
周围神经髓鞘诱导的EAN屏障完整性。
将进行电生理测试和组织学研究,以评估
周围神经脱髓鞘在EAN和神经内注射后。
使用的免疫学技术包括ELISA、C1固定-转移
测定和HPTLC。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANCINE J VRIESENDORP其他文献
FRANCINE J VRIESENDORP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANCINE J VRIESENDORP', 18)}}的其他基金
相似国自然基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the role of complement component 5a in ANCA-associated vasculitis
研究补体成分 5a 在 ANCA 相关血管炎中的作用
- 批准号:
MR/Y000854/1 - 财政年份:2024
- 资助金额:
$ 9.02万 - 项目类别:
Fellowship
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 9.02万 - 项目类别:
NSF Convergence Accelerator, Track M: TANDEM: Tensegrity-based Assistive aND rehabilitation Exosuits to complement human bioMechanics
NSF 融合加速器,轨道 M:TANDEM:基于张拉整体的辅助和康复外装,以补充人体生物力学
- 批准号:
2344385 - 财政年份:2024
- 资助金额:
$ 9.02万 - 项目类别:
Standard Grant
Development of a novel oral vaccine for fish: Synergy of chitosan nano particle and complement-mediated opsonization
新型鱼类口服疫苗的开发:壳聚糖纳米颗粒与补体介导的调理作用的协同作用
- 批准号:
24K17960 - 财政年份:2024
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Crosstalk between purinergic signaling and the complement system in sepsis-induced immunosuppression.
脓毒症引起的免疫抑制中嘌呤能信号传导与补体系统之间的串扰。
- 批准号:
23H03013 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
- 批准号:
10629550 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection
定义蜱唾液抑制补体对蜱传病毒进化和小鼠感染模型适应性免疫反应的影响
- 批准号:
10535945 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
急性至持续性风疹病毒感染期间获得的补体耐药性
- 批准号:
10645486 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
VCP 抑制补体途径治疗阿尔茨海默病
- 批准号:
10602757 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别: